Legend Biotech Corporation - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US52490G1022

SecurityLEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
InstitutionCitigroup Inc
Latest Disclosed Ownership79,949 shares
Latest Disclosed Value $ 1,446,277
Citigroup Inc ownership in LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 79,949 shares of Legend Biotech Corporation - Depositary Receipt (Common Stock) (US:LEGN) valued at $1,446,277 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 74,997 shares of Legend Biotech Corporation - Depositary Receipt (Common Stock). This represents a change in shares of 6.60% during the quarter. The current value of the position is $2,876,565 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (LEGN) in the form of stock options. The firm currently holds call options representing 30,000 of underlying shares valued at $542,700 USD and put options representing 30,000 of underlying shares valued at $542,700 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 79,949 4,952 6.60 1,446 -11.29 0.0003
2026-02-13 2025-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 74,997 27,521 57.97 1,630 5.30 0.0007
2025-11-10 2025-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 47,476 5,130 12.11 1,548 3.06 0.0007
2025-08-11 2025-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 42,346 4,183 10.96 1,503 16.07 0.0007
2025-05-12 2025-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 38,163 -7,385 -16.21 1,295 -12.69 0.0007
2025-02-12 2024-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 45,548 3,550 8.45 1,482 -27.57 0.0009
2024-11-12 2024-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 41,998 -1,482 -3.41 2,047 6.29 0.0012
2024-08-12 2024-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 43,480 3,776 9.51 1,926 -13.52 0.0012
2024-05-10 2024-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 39,704 -30,795 -43.68 2,227 -47.51 0.0015
2024-02-09 2023-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 70,499 -8,895 -11.20 4,242 -20.46 0.0030
2023-12-06 2023-09-30 13F/A-1 LEGEND BIOTECH SPONSORED ADS 52490G102 79,394 4,427 5.91 5,333 3.05 0.0040
2023-11-09 2023-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 79,394 4,427 5,333 0.0016
2023-08-10 2023-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 74,967 -8,103 -9.75 5,175 29.19 0.0034
2023-05-11 2023-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 83,070 7,265 9.58 4,006 5.84 0.0028
2023-02-09 2022-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 75,805 5,491 7.81 3,784 31.89 0.0030
2022-11-10 2022-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 70,314 -44,082 -38.53 2,869 -54.40 0.0021
2022-08-10 2022-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 114,396 53,094 86.61 6,291 182.36 0.0047
2022-05-12 2022-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 61,302 11,188 22.33 2,228 -4.62 0.0014
2022-02-10 2021-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 50,114 34,543 221.84 2,336 196.45 0.0013
2021-11-10 2021-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 15,571 7,828 101.10 788 147.80 0.0005
2021-08-10 2021-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 7,743 7,286 1,594.31 318 2,346.15 0.0002
2021-05-13 2021-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 457 -183 -28.59 13 -27.78 0.0000
2021-02-11 2020-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 640 640 18 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F LEGEND BIOTECH SPONSORED ADS Call 30,000 0.00 543 -16.87 n/a n/a n/a
2026-02-13 2025-12-31 13F LEGEND BIOTECH SPONSORED ADS Call 30,000 100.00 652 33.33 n/a n/a n/a
2025-11-10 2025-09-30 13F LEGEND BIOTECH SPONSORED ADS Call 15,000 -50.00 489 -54.04 n/a n/a n/a
2025-08-11 2025-06-30 13F LEGEND BIOTECH SPONSORED ADS Call 30,000 -65.28 1,065 -63.70 n/a n/a n/a
2025-05-12 2025-03-31 13F LEGEND BIOTECH SPONSORED ADS Call 86,400 188.00 2,932 200.31 n/a n/a n/a
2025-02-12 2024-12-31 13F LEGEND BIOTECH SPONSORED ADS Call 30,000 976 n/a n/a n/a
2024-02-09 2023-12-31 13F LEGEND BIOTECH SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A LEGEND BIOTECH SPONSORED ADS Call 24,900 1,673 n/a n/a n/a
2023-11-09 2023-09-30 13F LEGEND BIOTECH SPONSORED ADS Call 24,900 1,673 n/a n/a n/a
2023-08-10 2023-06-30 13F LEGEND BIOTECH SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-11 2023-03-31 13F LEGEND BIOTECH SPONSORED ADS Call 29,800 1,437 n/a n/a n/a
2023-02-09 2022-12-31 13F LEGEND BIOTECH SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F LEGEND BIOTECH SPONSORED ADS Call 29,800 88.61 1,216 39.93 n/a n/a n/a
2022-08-10 2022-06-30 13F LEGEND BIOTECH SPONSORED ADS Call 15,800 -21.00 869 19.53 n/a n/a n/a
2022-05-12 2022-03-31 13F LEGEND BIOTECH SPONSORED ADS Call 20,000 727 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F LEGEND BIOTECH SPONSORED ADS Put 30,000 0.00 543 -16.87 n/a n/a n/a
2026-02-13 2025-12-31 13F LEGEND BIOTECH SPONSORED ADS Put 30,000 100.00 652 33.33 n/a n/a n/a
2025-11-10 2025-09-30 13F LEGEND BIOTECH SPONSORED ADS Put 15,000 -50.00 489 -54.04 n/a n/a n/a
2025-08-11 2025-06-30 13F LEGEND BIOTECH SPONSORED ADS Put 30,000 -65.28 1,065 -63.70 n/a n/a n/a
2025-05-12 2025-03-31 13F LEGEND BIOTECH SPONSORED ADS Put 86,400 188.00 2,932 200.31 n/a n/a n/a
2025-02-12 2024-12-31 13F LEGEND BIOTECH SPONSORED ADS Put 30,000 976 n/a n/a n/a
2024-02-09 2023-12-31 13F LEGEND BIOTECH SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A LEGEND BIOTECH SPONSORED ADS Put 24,900 1,673 n/a n/a n/a
2023-11-09 2023-09-30 13F LEGEND BIOTECH SPONSORED ADS Put 24,900 1,673 n/a n/a n/a
2023-08-10 2023-06-30 13F LEGEND BIOTECH SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-11 2023-03-31 13F LEGEND BIOTECH SPONSORED ADS Put 29,800 1,437 n/a n/a n/a
2023-02-09 2022-12-31 13F LEGEND BIOTECH SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F LEGEND BIOTECH SPONSORED ADS Put 29,800 1,216 n/a n/a n/a
2022-08-10 2022-06-30 13F LEGEND BIOTECH SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F LEGEND BIOTECH SPONSORED ADS Put 20,000 727 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.